Pharmialabs (Cosmos Medical Invest. corp)
Business category 1 | ABS |
City ( of main office ) | Wilmington, US, United States |
Address | 1308 Delaware Avenue |
Phones | 1-800-6913143 |
Fax | 1 |
Web site | www.pharmialabs.com |
About | PHARMIALABS PharmiaLabs is a company dedicated to manufacturing herbal capsules for the improvement of health and well-being of men and women. Based on an international market research to point out current women's and men's needs and a medical research on the potential benefits of active components of natural herbs related to those needs, PharmiaLabs nowadays is able to offer a wide range of state of the art scientifically proven formulas. These 100 per cent natural formulas have been shaped into herbal tablets for optimal result achievement, while taking care of health. PharmiaLabs capsules are regulated by the Food and Drug Administration (FDA) pursuant to the requirements of the Federal Food, Drug and Cosmetic Act (FD & C Act) and the Fair Packaging and Labeling Act (FLPA) and other related laws. GMP (Good Manufacturing Practices) All our products have been developed in the best conditions and meet all the needed GMP & FDA requirements. Good Manufacturing Practices guidelines are followed as a system of processes, procedures and documentation to assure that our tablets have the identity, strength, composition, quality, and purity that it is represented to possess. PharmiLabs products follows GMP guidelines, which: Increases its creditability, allowing us to offer a competitive advantage in the marketplace. Demonstrates independent third-party verification of continuing conformance to GMP. Leading technology factories USA Our leading technology PharmiaLabs factories in USA, allow us to reach an incomparable degree of quality in our products, which render them as unique and completely efficient. All the leading technologies in the health and beauty fields are present in PharmiaLabs products, so as to guarantee an unbeatable quality for the entire satisfaction of our clients. |
Date | 2011 Oct 29, 15:10 |